Smole Biopharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 7 Months
About Smole Biopharma
Smole Biopharma Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 June 2022 (Two years and seven months 12 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Durairaj Navaneethasivakumar, Chandra Gurusamy, Krishnan Hema, and One other member serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200TZ2022PTC039252
-
Company No.
039252
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 2022
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Smole Biopharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Durairaj Navaneethasivakumar
|
Director | 22-Jun-2022 | Current |
|
Chandra Gurusamy
|
Director | 22-Jun-2022 | Current |
|
Krishnan Hema
|
Director | 22-Jun-2022 | Current |
|
Mahalingam Murugesan
|
Director | 22-Jun-2022 | Current |
Financial Performance of Smole Biopharma.
Enhance accessibility to Smole Biopharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smole Biopharma?
Unlock access to Smole Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Confederation Of Affirmative IndustriesDurairaj Navaneethasivakumar is a mutual person
-
Zmole Therapeutics Private Limited
Chandra Gurusamy, Krishnan Hema and 1 more are mutual person
-
Coco Vap Private Limited
Krishnan Hema and Mahalingam Murugesan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Smole Biopharma?
Unlock and access historical data on people associated with Smole Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smole Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smole Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.